Search results
Results from the Health.Zone Content Network
United Therapeutics owns a 415,000-square-foot combination laboratory and office building complex in Silver Spring, Maryland. The facility serves as the company's co-headquarters and is used for commercial manufacturing of active pharmaceutical ingredients and finished dosage form products. United Therapeutics also owns a 380,000-square-foot ...
Kadmon Corporation, LLC. Kadmon Corporation (originally Kadmon Pharmaceuticals) is a biopharmaceutical company based in New York City. It also has operations in Warrendale, PA and Brighton, MA. The company was founded in 2009 by Samuel D. Waksal, [2] [3] founder and former CEO of ImClone Systems, now fully merged into Eli Lilly and Company.
Formation of Amneal Pharmaceuticals Inc. In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc. to form Amneal Pharmaceuticals, Inc. The FTC described the merger as having a value of US$1.45 billion, and required the companies to divest several marketed products and development projects as a condition of the approval.
Show comments. AstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by demand for its blockbuster drugs and steady sales from partnered medicines and ...
DMG Mori Co., Ltd. (DMG森精機株式会社, DMG Mori Seiki Kabushiki-gaisha) (formerly Mori Seiki Co., Ltd. and DMG Mori Seiki Co., Ltd.) is a Japanese company headquartered in Tokyo and Nara City, engaged primarily in the manufacture and sale of machine tools. [3] [4] [5] Since its establishment, the business has become the largest machine ...
Eli Lilly raised both ends of its 2024 revenue forecast by $2 billion and now expects $42.4 billion to $43.6 billion for the year. The drugmaker also raised its annual profit forecast by $1.30 per ...
April 30, 2024 at 5:03 AM. (Reuters) - GE HealthCare Technologies missed first-quarter revenue estimates on Tuesday, hurt by lower sales in China market and weaker-than-expected demand for its ...
Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company. [3] It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. [4] Depomed was founded in 1995 and is headquartered in Newark, California. [5] It is a publicly traded company on NASDAQ, with several ...